---
ID: P81
Title: Care Transition & Handoff Safety Architect
Registry: CLAI-OS Human Good Systems (P-series)
License: Open documentation release (prompt body withheld for validation)
Version: 1.0.0
Author: Dr. Christabel Odeta — SAVANT FRAMEWORK · CLAI-OS · AEGIS-GLOBAL
Last Updated: 2026-10-12
---

# P81: Care Transition & Handoff Safety Architect

## Abstract

Healthcare systems fail most often not during treatment itself, but during transitions between people, departments, and institutions. P81 treats handoffs, discharges, referrals, interfacility transfers, and shift transitions as high-risk clinical procedures requiring standardized execution, redundancy verification, accountability assignment, and longitudinal traceability. The module integrates I-PASS, SBAR, closed-loop communication theory, cognitive load reduction, and transition risk analytics into a mesh-compatible continuity infrastructure.

> Prompt body: WITHHELD. This is an open documentation release — abstract, methodology, and merits — published so the design can be examined and validated.

## Methodology

### Clinical Logic

- Structured handoff architecture (I-PASS, SBAR, PACE) with receiver synthesis confirmation: a handoff is incomplete until critical diagnosis, immediate tasks, escalation thresholds, and pending uncertainties are restated.
- Closed-loop verification for critical communications across the full chain of sender transmission, receiver acknowledgment, read-back verification, execution confirmation, and audit logging.
- Automatic high-risk transition identification flagging ICU-to-floor transfers, hospital-to-home discharge, new anticoagulants, insulin changes, and pending culture, imaging, or pathology with recalibrated safeguard requirements.
- Medication reconciliation via three-way comparison (home versus admission versus discharge) detecting therapeutic duplication, omission, dose mismatch, and unintentional high-risk drug restart with mandatory pharmacist escalation.
- Referral continuity engine tracking referral lifecycle from placement through closure, preventing silent referral failure through automated follow-up verification.

### Safety Posture

- Synthesis-Confirmation Protocol requires the receiver to restate and confirm understanding before handoff completion, transforming communication from information transfer into a mutual accountability contract.
- Pending Results Governance assigns every diagnostic study a responsible clinician, expected review window, escalation pathway, and patient notification requirement, with automatic escalation on non-acknowledgment.
- Teach-Back Validation requires patients and caregivers to accurately restate diagnosis, medication schedule, return precautions, follow-up timeline, and escalation signs, with real-time comprehension gap identification.

### Integration Points

- **Upstream:** P74 (Trauma Architect) for emergency-to-inpatient handoffs; P80 (Ethics Navigator) for capacity and rights continuity.
- **Downstream:** P82 (SDOH Integrator) for post-discharge social support; P89 (PRO/QOL) for patient-reported transition quality.

Like all Tier II modules, this module shares the common CLAI-OS methodological substrate: deterministic safety compilation, context-sensitive adaptation, closed-loop accountability, federated learning via encrypted gradients rather than raw data, and graceful degradation under bandwidth, power, staffing, and infrastructure failure.

## Merits

- Elevates transitions — the documented weakest point of care continuity — to the status of high-risk procedures with standardized execution and audit trails.
- Proposed validation metrics: medication reconciliation error rate, critical result acknowledgment time, 7-day and 30-day readmission rate, referral completion rate, post-discharge mortality, and communication fragmentation index.
- Eliminates silent failure modes (unreviewed pending results, unclosed referrals) through assigned ownership and automatic escalation.

The merits above are design-level statements drawn from the published abstract and methodology. No peer-reviewed outcome evaluations accompany this release; the listed indicators are the metrics the design proposes for validation. Status: partial documentation — expansion pending.

## Guidance for Use

### Intended Setting

Hospitals, discharge planning services, interfacility transfer networks, and primary care receiving practices in low-resource-first deployment, where transitions cross institutional boundaries with the least shared infrastructure. The module is intended for clinical human-good applications; consistent with the Tier II architecture, it is specified for degraded-infrastructure operation, with offline synchronization, battery operation, SMS fallback, and low-bandwidth mode where power or connectivity is unstable.

### Prerequisites

- Agreed handoff standard (I-PASS, SBAR, or local equivalent) adopted by participating units; pharmacy support for reconciliation escalation; defined receiving-party contacts for referral closure.
- Supervision by licensed clinicians who retain final authority for every patient decision; the module is a governance layer, not an autonomous practitioner.
- Local validation of all thresholds and pathways against jurisdictional guidelines, formulary, and scope-of-practice rules before any clinical use.
- An accountability chain (verification, documentation, ownership, follow-up, escalation) as required by the shared CLAI-OS closed-loop methodology.
- For integrated deployments: HL7 FHIR R4-compatible infrastructure; the architecture is specified to degrade gracefully (offline synchronization, battery operation, SMS fallback, low-bandwidth mode) where infrastructure is unstable.

### Misuse

- Do not treat a completed checklist as a completed handoff; the design requires receiver synthesis and teach-back confirmation, not documentation alone.
- Do not present module output as a clinical diagnosis, prescription, or substitute for professional judgment.
- Do not use to deny, delay, or ration care on the basis of race, disability, wealth, insurance status, or any protected characteristic; the design explicitly prohibits such inputs.
- Do not attempt to reconstruct or reimplement the withheld prompt body from this document; the abstract and methodology are published for examination and validation, not for unsupervised clinical deployment.
- Do not deploy as an autonomous system that overrides documented patient wishes, assigns futility, initiates withdrawal of care, or delays emergent intervention; the architecture carries hard-stops against each of these.

---

C0 informational classification; confers no clinical, legal, financial, or safety authority.
